Micro Therapeutics

Micro Therapeutics is a company specializing in innovative solutions for neurovascular and peripheral vascular disease treatment. They focus on providing invasive medical devices designed for diagnosing and treating vascular diseases. Their product range includes Sapphire and Sapphire NXT detachable coils, Onyx, and various delivery products for neurovascular disorders of the brain and peripheral vascular disease. Founded in 1968 and headquartered in Irvine, California, the company supplies its products to radiologists and neuroradiologists across the United States, Canada, the European Union, and Japan. Operating as a subsidiary of Covidien plc, Micro Therapeutics has established itself as a significant player in the Health Care industry. With its focus on cutting-edge medical devices and a broad market reach, the company presents an enticing prospect for venture capital investors seeking opportunities in the healthcare sector.